Welcoming Message History and Mission Programmes Location Organization Notice
Events - Seminar - Workshop - Forum - Expert Meeting - Capacity-Building
Research Publications Competition Policy Trends Family Database in the Asia-Pacfic Region Links
Expert Meeting 2016-09-22~2016-09-23
Summary |
ㅁ Date: 22 - 23 September 2016 ㅁ Venue: Novotel Ambassador Gangnam, Seoul, Korea ㅁ Hosted by OECD KOREA Policy Centre (Health and Social Policy Programme), OECD, WHO WPRO, WHO Collaborating Centre (at SNU) ㅁ Participation: 40 persons ㅇ International organizations: OECD, WHO, WHO WPRO, WHO SEARO, UNDP, ADB |
Programme Summary |
|
ㅁ 22 September 2016
1.1 Opening and welcome address
ㆍ Ra, Sung-woong, Director General , OECD KOREA Policy Centre
ㆍ David Newby, Coordinator, WHO WPRO
ㆍ Sun-Young Kim, Professor, WHO Collaborating Centre (at SNU)
ㆍ Luca Lorenzoni, Health Economist, OECD
Overview of meeting objectives
Nomination of Chair and co-chair
Participant introduction
Group photo
1.2 Initiatives promoting wider access to medicines
ㆍ Global update on access to medicines – Inthira Yamabhai, WHO HQ
ㆍ Regional update on access to medicines in Asia Pacific – Klara Tisocki, WHO SEARO
ㆍ Pharmaceutical Country Profiles and PIEMEDS – Uhjin Kim, WHO WPRO
ㆍ The effect of generic medicines policies on price reductions: Lessons from Australia, Korea, Singapore,
and New Zealand – Libby Roughead, Temporary Adviser
1.3 Financing options for medicines
ㆍ Health at a glance Asia Pacific 2016 – Luca Lorenzoni, OECD
ㆍ Pharmacoeconomics and resource allocation for high cost medicines – David Newby, WHO WPRO
ㆍ Financing and benefit package decisions – Soonman Kwon, ADB
1.4 Group Work
ㆍ Root cause analysis and identification of challenges in access to high cost medicines
ㆍ Group work feedback and discussions
ㅁ 23 September 2016
2.1 Factors that influence health technology adoption
ㆍ Considerations in expanding access to high-cost medicines in low- and middle-income countries:
Financial, economic, organizational, and ethical issues – Sun-Young Kim, WHO Collaborating Centre
ㆍ Looking back on HTA during Universal Coverage Scheme implementation: Lessons from Thailand
– Netnapis Suchonwanich, HITAP, Thailand
ㆍ Challenges in introducing a high cost medicines in Vietnam – Vu Thi Chi, DAV, Vietnam
ㆍ Panel Discussion: Factors that influence health technology adoption
– Facilitator: Soonman Kwon
– Panelists: Inthira Yamabhai, Sun-Young Kim, Andrew Wilson, Luca Lorenzoni, Libby Rougheadd
2.2 Country cases
ㆍ Access to oncology medication in Australia – Andrew Wilson, Temporary Adviser
ㆍ Access to HepC medicine: experience from Korea – Junho Jang, HIRA, Korea
ㆍ Lao PDR’s experience in introducing a high cost medicines – Sivong Sengaloundeth, FDD, Lao PDR
ㆍ High cost medicines: what do we do – Abida Syed M. Haq, MoH, Malaysia
2.3 Group work
ㆍ Identification of factors and players that influence health technology adoption in countries
ㆍ Group work feedback and discussions
2.4 Conclusions and Closure
ㆍ Meeting summary – Plenary Chair
ㆍ Comments by the meeting organizers
ㆍ Closing remarks – Ra, Sung-woong, Director General, OECD KOREA Policy Centre